other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}

Adviser Profile

As of Date 03/27/2024
Adviser Type - Large advisory firm
Number of Employees 8 14.29%
of those in investment advisory functions 7 16.67%
Registration SEC, Approved, 12/19/2003
AUM* 647,896,107 19.38%
of that, discretionary 647,896,107 19.38%
Private Fund GAV* 647,896,107 -40.18%
Avg Account Size 161,974,027 19.38%
SMA’s No
Private Funds 6
Contact Info 310 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
742M 636M 530M 424M 318M 212M 106M
2015 2016 2017 2018 2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeHedge Fund Count6 GAV$647,896,107

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser AR ASSET MANAGEMENT, INC. Hedge Fund135.2m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV135.2m AUM542.1m #Funds3
Adviser FORT, L.P. Hedge Fund85.1m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV85.1m AUM358.9m #Funds2
Adviser ENGLE CAPITAL MANAGEMENT, L.P. Hedge Fund408.9m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV408.9m AUM489.4m #Funds1
Adviser LOGAN STONE Hedge Fund552.3m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV552.3m AUM805.4m #Funds2
Adviser SHAH CAPITAL MANAGEMENT Hedge Fund444.5m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV444.5m AUM514.6m #Funds1
Adviser ORIBEL CAPITAL MANAGEMENT, LP Hedge Fund101.0m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV101.0m AUM1.2b #Funds1
Adviser INCOME PARTNERS ASSET MANAGEMENT (HK) LIMITED Hedge Fund8.3m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV8.3m AUM368.3m #Funds1
Adviser SOLAS CAPITAL MANAGEMENT, LLC Hedge Fund102.2m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV102.2m AUM599.1m #Funds2
Adviser RIVA RIDGE CAPITAL MANAGEMENT LP Hedge Fund569.1m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV569.1m AUM606.8m #Funds4
Adviser KEENAN CAPITAL, LLC Hedge Fund662.1m Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV662.1m AUM662.1m #Funds1

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker78464A870 Stock NameSPDR S&P BIOTECH ETF $ Position$41,256,414 % Position10.00% $ Change1.00% # Change3.00%
Stck Ticker85916J409 Stock NameSTEREOTAXIS INC $ Position$24,898,608 % Position6.00% $ Change-30.00% # Change0.00%
Stck TickerN5749R100 Stock NameMERUS N V $ Position$24,226,861 % Position6.00% $ Change42.00% # Change8.00%
Stck Ticker76155X100 Stock NameREVOLUTION MEDICINES INC $ Position$19,866,606 % Position5.00% $ Change20.00% # Change0.00%
Stck Ticker23282W605 Stock NameCYTOKINETICS INC $ Position$21,569,058 % Position5.00% $ Change-23.00% # Change0.00%
Stck Ticker45166A102 Stock NameIDEAYA BIOSCIENCES INC $ Position$14,823,898 % Position4.00% $ Change-24.00% # Change-5.00%
Stck Ticker464287556 Stock NameISHARES NASDAQ BIOTECH INDX $ Position$14,069,150 % Position3.00% $ Change0.00% # Change0.00%
Stck Ticker09627Y109 Stock NameBLUEPRINT MEDICINES CORP $ Position$11,291,356 % Position3.00% $ Change11.00% # Change-2.00%
Stck Ticker04963C209 Stock NameATRICURE INC $ Position$14,553,969 % Position3.00% $ Change77.00% # Change136.00%
Stck Ticker98420N105 Stock NameXENON PHARMACEUTICALS INC $ Position$10,673,084 % Position3.00% $ Change-9.00% # Change0.00%

Brochure Summary

Overview

A.AdvisoryFirm Adviser is a Delaware limited liability company that commenced operations in December 13, 1999, and is owned and controlled by Dr. Nathan Fischel and Dr. Fariba Ghodsian. B.Specialization Adviser has long experience and a strong background in providing investment advisory services with respect to the analysis of companies in the
life science field. C.AdvisoryServices Adviser provides investment advisory services with respect to one or more private investment funds (each, a “Fund”). D.WrapFeePrograms Not applicable. E.RegulatoryAssetsUnderManagementasofFebruary28,2024. Discretionary: $ 647.9M Non‐Discretionary: $0